Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G Goss, L L Siu, I Gauthier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2006
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115
J A Maroun, K Belanger, L Seymour, et al.
FEMS Microbiology Ecology
|
June 30, 2026
Geochemistry shapes microbial diversity and selected functional traits in flowback and produced waters from hydraulically fractured formations
Ya Deng, Mikayla A Borton, Camilla L Nesbø, et al.
General and Comparative Endocrinology
|
October 8, 2008
Signal transduction in multifactorial neuroendocrine control of gonadotropin secretion and synthesis in teleosts-studies on the goldfish model
John P Chang, James D Johnson, Grant R Sawisky, et al.
Nanotoxicology
|
February 21, 2013
Mechanistic insights into the effect of nanoparticles on zebrafish hatch
Kimberly Jessica Ong, Xinxin Zhao, Maria E Thistle, et al.
Plos One
|
March 13, 2014
Widespread nanoparticle-assay interference: implications for nanotoxicity testing
Kimberly J Ong, Tyson J MacCormack, Rhett J Clark, et al.
Environmental Microbiology
|
April 13, 2022
Complex impacts of hydraulic fracturing return fluids on soil microbial community respiration, structure and functional potentials
Cheng Zhong, Camilla L Nesbø, Konstantin von Gunten, et al.
Investigational New Drugs
|
March 4, 2005
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G Goss, H Hirte, W H Miller, et al.
Environmental Science & Technology
|
July 17, 2015
Adapting OECD Aquatic Toxicity Tests for Use with Manufactured Nanomaterials: Key Issues and Consensus Recommendations
Elijah J Petersen, Stephen A Diamond, Alan J Kennedy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 3, 2018
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials
G Goss, C-M Tsai, F A Shepherd, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G Goss, L L Siu, I Gauthier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2006
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115
J A Maroun, K Belanger, L Seymour, et al.
FEMS Microbiology Ecology
|
June 30, 2026
Geochemistry shapes microbial diversity and selected functional traits in flowback and produced waters from hydraulically fractured formations
Ya Deng, Mikayla A Borton, Camilla L Nesbø, et al.
General and Comparative Endocrinology
|
October 8, 2008
Signal transduction in multifactorial neuroendocrine control of gonadotropin secretion and synthesis in teleosts-studies on the goldfish model
John P Chang, James D Johnson, Grant R Sawisky, et al.
Nanotoxicology
|
February 21, 2013
Mechanistic insights into the effect of nanoparticles on zebrafish hatch
Kimberly Jessica Ong, Xinxin Zhao, Maria E Thistle, et al.
Plos One
|
March 13, 2014
Widespread nanoparticle-assay interference: implications for nanotoxicity testing
Kimberly J Ong, Tyson J MacCormack, Rhett J Clark, et al.
Environmental Microbiology
|
April 13, 2022
Complex impacts of hydraulic fracturing return fluids on soil microbial community respiration, structure and functional potentials
Cheng Zhong, Camilla L Nesbø, Konstantin von Gunten, et al.
Investigational New Drugs
|
March 4, 2005
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G Goss, H Hirte, W H Miller, et al.
Environmental Science & Technology
|
July 17, 2015
Adapting OECD Aquatic Toxicity Tests for Use with Manufactured Nanomaterials: Key Issues and Consensus Recommendations
Elijah J Petersen, Stephen A Diamond, Alan J Kennedy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 3, 2018
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials
G Goss, C-M Tsai, F A Shepherd, et al.
Page
of 25